不同剂量吉西他滨辅助化疗根治术后胰腺癌的随机对照临床研究

禹旭平

doi:10.13406/j.cnki.cyxb.2010.03.026

您当前的位置：

首页 >

文章列表页 >

不同剂量吉西他滨辅助化疗根治术后胰腺癌的随机对照临床研究

临床研究 | 更新时间：2024-01-17

- 不同剂量吉西他滨辅助化疗根治术后胰腺癌的随机对照临床研究
- Different doses of gemcitabine chemotherapy after radical resection of pancreatic cancer:a randomized controlled clinical study
- 重庆医科大学学报 2010年35卷第3期页码：436-439
- 作者机构：
  
  湖南省邵阳市中心医院普外科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2010.03.026
  中图分类号： R735.9
- 纸质出版日期：2010，
扫描看全文
[1]禹旭平.不同剂量吉西他滨辅助化疗根治术后胰腺癌的随机对照临床研究[J].重庆医科大学学报,2010,35(03):436-439.

YU Xu-ping. Different doses of gemcitabine chemotherapy after radical resection of pancreatic cancer:a randomized controlled clinical study[J]. Journal of Chongqing Medical University, 2010,35(3):436-439.
[1]禹旭平.不同剂量吉西他滨辅助化疗根治术后胰腺癌的随机对照临床研究[J].重庆医科大学学报,2010,35(03):436-439. DOI： 10.13406/j.cnki.cyxb.2010.03.026.

YU Xu-ping. Different doses of gemcitabine chemotherapy after radical resection of pancreatic cancer:a randomized controlled clinical study[J]. Journal of Chongqing Medical University, 2010,35(3):436-439. DOI： 10.13406/j.cnki.cyxb.2010.03.026.

摘要

目的:比较标准剂量和小剂量吉西他滨对根治术后胰腺癌辅助化疗的疗效及安全性。方法:采用随机双盲平行对照的临床试验方法

以疾病相关症状改善、生存分析及毒副反应为结局终点指标

比较标准剂量（1000mg/m2）和小剂量（500mg/m2）吉西他滨辅助化疗根治术后胰腺癌的疗效及安全性。结果:2005年1月至2007年3月间符合标准的患者共83例

随机分组后患者性别、年龄等具有基线可比性（P>0.05）。意向性治疗分析和方案分析均显示标准剂量组和小剂量组疾病相关症状改善及术后生存均相当（P>0.05）

而毒副反应

尤其是血液系统毒性在标准剂量组高于小剂量组（P<0.05）。结论:小剂量吉西他滨对根治术后胰腺癌辅助化疗的疗效和标准剂量相当

而毒副反应减少。

Abstract

Objective:To compare standard-dose and low-dose gemcitabine adjuvant chemotherapy for pancreatic cancer after radical operation

assessing its efficacy and safety.Methods:A randomized double-blind

parallel-controlled clinical trial was used in this study

disease-related symptoms improved

survival analysis and toxicity as the end point for the outcome indicators to compare standard-dose(1 000 mg/m2) and low-dose(500 mg/m2) gemcitabine adjuvant chemotherapy after radical resection of pancreatic cancer.Results:From January 2005 to March 2007

83 patients who meet the criteria were enrolled in the study.The baseline in two groups was the same(P> 0.05).Intention to treat analysis and per-protocol analysis have shown that disease-related symptom improvement and survival were the same in two groups(P>0.05)

but toxicity

especially hematologic toxicity in standard-dose group was higher than that in the low-dose group(P<0.05).Conclusion:Low-dose gemcitabine was efficacy for pancreatic cancer after radical resection

but the toxicity reduced compared with standard-dose chemotherapy.

关键词

胰腺癌根治术化疗吉西他滨随机对照临床研究

Keywords

pancreatic cancerRadical resection of pancreatic cancerchemotherapygemcitabineRandomized controlled clinical study

references

浏览量

130

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

GEM联合CBP与NVB联合DDP治疗老年NSCLC对比研究

维迪西妥单抗和术后化疗用于治疗人表皮生长因子受体2阳性的局限性尿路上皮癌患者的临床疗效分析

经尿道膀胱肿瘤黏膜下剥离术联合术中膀胱黏膜下注射吉西他滨治疗膀胱非肌层浸润性尿路上皮癌的疗效观察（附7例报告）

炭疽毒素受体2表达受miR-145-5p调控在胰腺癌的作用机制研究

渐进性肌肉放松训练对肺癌化疗患者情绪与应对方式的影响